The Filing Desk

Aemetis

AMTX · Nasdaq · Energy · Financials, fiscal 2016 to 2025

AMTX · Last close · November 13, 2026
$1.20
Value Aemetis yourself

Aemetis' revenue fell 26.2% to $198 million in fiscal 2025. Its operating margin was −18.8%, down from −15.1% a year earlier. Free cash flow was −$23 million. The diluted share count rose 30.7%.

AEMETIS, INC Latest fiscal year ended December 31, 2025 10-K filed March 16, 2026 · 0001437749-26-008289 Updated
Revenue
$198M
26.2%
Operating margin
−18.8%
3.7 pts
Net income
−$77M
 
Free cash flow
−$23M
 
Return on capital
−33.4%
2.1 pts
Market cap
$87M
Nov 13 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Aemetis does

Aemetis makes fuels from farm products and waste. It is based in Cupertino, California, and says it focuses on renewable natural gas and renewable fuels with a lower carbon footprint. It has three main operations.

In California it runs an ethanol plant in Keyes that can make 65 million gallons a year. The plant also sells its leftover grain products as animal feed to local dairies and feedlots, and sells carbon dioxide to the food and beverage industries. Also in California, it collects biogas from dairy waste in twelve digesters and turns it into renewable natural gas that goes into the utility pipeline for use as vehicle fuel. In India it runs a plant in Kakinada that can make about 80 million gallons a year of biodiesel from vegetable oils and animal waste. It also sells the glycerin that the process leaves over.

Aemetis says it competes with makers of petroleum-based fuels and with other companies offering alternatives to them. Many of them have more resources and experience than it has. It is also building more dairy digesters, a fuel station for its natural gas, and other projects.

Its biggest risks, as it describes them

  • Losses so far, and a debt load that could limit its cash flow and force it to scale back.
  • Its reliance on outside financing, and the chance it cannot repay or refinance its Third Eye Capital debt when due.
  • Its profit depends on the gap between feedstock and energy costs and the prices of fuel and animal feed.
  • Its reliance on tax credits, carbon credits and grants that could end or shrink.
  • Its dependence on working capital agreements with J.D. Heiskell and other key vendors.
From Aemetis's annual report on Form 10-K, filed March 16, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

Aemetis lost money in fiscal 2025: a net loss of $77 million.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments84315
Debt incl. finance leases206286321368385
Net debt (negative means net cash)198282318367380
Net debt to EBITDA—————
Debt to equity—————
Interest coverage−0.7x−1.2x−0.9x−0.9x−0.7x
Current ratio0.3x0.2x0.4x0.3x0.1x
Quick ratio0.2x0.1x0.2x0.1x0.0x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Aemetis' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Aemetis shares on the open market, and 1 insider sold $20,500.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Jun 10, 2026Timothy Alan SimonDirectorSold10,000$2.05$20,500Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score7 of 92 of 93 of 9
Rule of 40149.6%226.8%−37.7%
Altman Z''−9.19−11.17−18.25
Accruals ratio−26.7%−21.7%−30.9%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailFail
Cash from operations is positivePassFailPass
Return on assets rosePassFailPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailFail
Current ratio rosePassFailFail
Share count didn't riseFailFailFail
Gross margin rosePassFailFail
Revenue rose relative to assetsPassPassFail
F-score7 of 92 of 93 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Aemetis side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
AemetisFY25−26.2%−18.8%−11.5%−33.4%—3
GevoFY25849.3%−12.6%−27.1%−3.5%16.5x3Compare
FutureFuelFY25−60.6%−55.4%−48.0%———Compare
Clean Energy FuelsFY252.2%−37.6%14.1%−17.9%—5Compare
REX American ResourcesFY251.2%—7.6%———Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue1431501722021662122877268198
Revenue growth−2.4%4.9%14.2%17.8%−18.0%28.0%−86.7%174.6%246.7%−26.2%
Gross profit123513118−62−1−1
Research and development02000000——
Operating income−1−12−11−5−6−16−34−37−40−37
Net income−16−32−36−40−37−47−108−46−88−77
Diluted EPS (US$)−0.79−1.53−1.63−1.75−1.74−1.54−3.12−1.22−1.91−1.28
Diluted shares (millions)20202020213135384660
Cash flow
Cash from operations0−9−6−22−21−2314−333
Capital expenditure1149192739332026
Free cash flow−0−10−10−11−17−47−62−19−53−23
Dividends paid0000000000
Share buybacks0000000000
Acquisitions0000000000
Stock-based compensation1111146886
Balance sheet at fiscal year end
Cash and short-term investments2011184315
Debt incl. finance leases110152173197246206286321368385
Total assets789492100125161207243259260
Total liabilities128174207254310281409460523567
Shareholders' equity−50−78−116−154−185−120−202−217−264−307
Margins and ratios
Gross margin8.1%2.2%3.1%6.3%6.7%3.8%−19.7%2.6%−0.2%−0.4%
Operating margin−0.6%−8.1%−6.4%−2.4%−3.7%−7.5%−122.4%−48.5%−15.1%−18.8%
Net margin−10.9%−21.2%−21.2%−19.5%−22.1%−22.2%−383.3%−60.1%−32.7%−39.0%
Free cash flow margin−0.2%−6.5%−5.6%−5.2%−10.2%−22.3%−220.6%−25.0%−19.9%−11.5%
Rule of 40 (growth + FCF margin)−2.6%−1.6%8.7%12.5%−28.2%5.7%−307.4%149.6%226.8%−37.7%
Return on capital−1.0%−14.8%−13.6%−8.0%−9.4%−18.1%−34.5%−32.6%−31.3%−33.4%
Return on equity——————————
Return on assets−19.4%−36.9%−39.0%−41.2%−32.6%−33.0%−58.6%−20.6%−34.8%−29.7%
Net debt to EBITDA26.9x—————————
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Aemetis' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Aemetis.